Author's reply
2006

Author's Reply on Clinical Trials Registration

publication

Author Information

Author(s): Karmela Krleža-Jerić

Primary Institution: Canadian Institutes of Health Research

Conclusion

Proper registration of clinical trial protocols is essential for transparency and informed decision-making in medicine.

Supporting Evidence

  • GSK is committed to registering its trial protocols and results.
  • Proper registration will help restore public confidence in the pharmaceutical industry.
  • Registration of trial protocols is the first step needed for transparency.

Takeaway

This article talks about how important it is for companies to share information about their medical trials so that doctors and patients can make better choices.

Potential Biases

The author points out that industry registries may not be unbiased.

Limitations

The author acknowledges that not all data for all trials will be registered.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030167

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication